Daniel J. Burch, M.D., is Global TA Head & VP for CNS at PPDi. Dr. Burch holds an MD from Vanderbilt University and an MBA from the Wharton School, University of Pennsylvania. He completed a residency in Internal Medicine at Vanderbilt University School of Medicine and a Fellowship in Infectious Diseases at Washington University School of Medicine. Dr. Burch has worked in the pharmaceutical/biotech industry for a total of twenty years at Abbott Laboratories, SmithKline Beecham, GlaxoSmithKline, and CeNeRx BioPharma. His most recent posts were Senior Vice President, Neurosciences Medicines Development Centre at GSK and Executive Vice President of Research and Development and Chief Medical Officer of CeNeRx Biopharma. He was appointed to his current position in September 2012.